Dysthymia in neurological disorders

Dysthymia is characterized by long-lasting periods of lowered mood. Epidemiological studies in the USA and Europe have demonstrated that the prevalence of dysthymia is at least 3% of the general population. Its pervasive occurrence makes dysthymia a public health problem worldwide. One feature of th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Akiskal, H.S., Bolis, C.L., Cazzullo, C., Costa E Silva, J.A., Gentil, V., Lecrubier, Y., Licinio, J., Linden, M., Lopez-Ibor, J.J., Ndiaye, I.P., Pani, L., Prilipko, L., Robertson, M.M., Robinson, R.G., Starkstein, S.E., Thomas, P., Wang, Y., Wong, M.-L.
Formato: JOUR
Materias:
Alzheimer's disease
Classification
Corticotropin-releasing hormone
Dopamine
Dysthymia
Epilepsy
Imaging techniques
Multiple sclerosis
Nervous system diseases
Parkinson's disease
Stroke
classification
conference paper
dysthymia
human
neurologic disease
world health organization
Dysthymic Disorder
Humans
Nervous System Diseases
World Health Organization
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_13594184_v1_n6_p478_Akiskal
Aporte de:
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires
id todo:paper_13594184_v1_n6_p478_Akiskal
record_format dspace
spelling todo:paper_13594184_v1_n6_p478_Akiskal2023-10-03T16:10:33Z Dysthymia in neurological disorders Akiskal, H.S. Bolis, C.L. Cazzullo, C. Costa E Silva, J.A. Gentil, V. Lecrubier, Y. Licinio, J. Linden, M. Lopez-Ibor, J.J. Ndiaye, I.P. Pani, L. Prilipko, L. Robertson, M.M. Robinson, R.G. Starkstein, S.E. Thomas, P. Wang, Y. Wong, M.-L. Alzheimer's disease Classification Corticotropin-releasing hormone Dopamine Dysthymia Epilepsy Imaging techniques Multiple sclerosis Nervous system diseases Parkinson's disease Stroke classification conference paper dysthymia human neurologic disease world health organization Dysthymic Disorder Humans Nervous System Diseases World Health Organization Dysthymia is characterized by long-lasting periods of lowered mood. Epidemiological studies in the USA and Europe have demonstrated that the prevalence of dysthymia is at least 3% of the general population. Its pervasive occurrence makes dysthymia a public health problem worldwide. One feature of this disorder is its co-occurrence with medical and neurological disorders. A World Health Organization meeting on dysthymia in neurological disorders was held in Geneva, 1-3 July 1996 to address this topic. Some of the major goals of this meeting were to clarify the definition of dysthymia in the presence of neurological disorders and to evaluate current research in the field, to point out new areas for investigation, and to discuss current psychological and pharmacological treatments for dysthymia in neurological disorders. The potential roles of neuroendocrine and molecular mechanisms in dysthymia were identified through specific problems related to dysthymia occurring in disorders such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis and epilepsy. This meeting provided direction and opportunity for future studies in the under-recognized and under-investigated relationship between dysthymia and neurological disorders. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_13594184_v1_n6_p478_Akiskal
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Alzheimer's disease
Classification
Corticotropin-releasing hormone
Dopamine
Dysthymia
Epilepsy
Imaging techniques
Multiple sclerosis
Nervous system diseases
Parkinson's disease
Stroke
classification
conference paper
dysthymia
human
neurologic disease
world health organization
Dysthymic Disorder
Humans
Nervous System Diseases
World Health Organization
spellingShingle Alzheimer's disease
Classification
Corticotropin-releasing hormone
Dopamine
Dysthymia
Epilepsy
Imaging techniques
Multiple sclerosis
Nervous system diseases
Parkinson's disease
Stroke
classification
conference paper
dysthymia
human
neurologic disease
world health organization
Dysthymic Disorder
Humans
Nervous System Diseases
World Health Organization
Akiskal, H.S.
Bolis, C.L.
Cazzullo, C.
Costa E Silva, J.A.
Gentil, V.
Lecrubier, Y.
Licinio, J.
Linden, M.
Lopez-Ibor, J.J.
Ndiaye, I.P.
Pani, L.
Prilipko, L.
Robertson, M.M.
Robinson, R.G.
Starkstein, S.E.
Thomas, P.
Wang, Y.
Wong, M.-L.
Dysthymia in neurological disorders
topic_facet Alzheimer's disease
Classification
Corticotropin-releasing hormone
Dopamine
Dysthymia
Epilepsy
Imaging techniques
Multiple sclerosis
Nervous system diseases
Parkinson's disease
Stroke
classification
conference paper
dysthymia
human
neurologic disease
world health organization
Dysthymic Disorder
Humans
Nervous System Diseases
World Health Organization
description Dysthymia is characterized by long-lasting periods of lowered mood. Epidemiological studies in the USA and Europe have demonstrated that the prevalence of dysthymia is at least 3% of the general population. Its pervasive occurrence makes dysthymia a public health problem worldwide. One feature of this disorder is its co-occurrence with medical and neurological disorders. A World Health Organization meeting on dysthymia in neurological disorders was held in Geneva, 1-3 July 1996 to address this topic. Some of the major goals of this meeting were to clarify the definition of dysthymia in the presence of neurological disorders and to evaluate current research in the field, to point out new areas for investigation, and to discuss current psychological and pharmacological treatments for dysthymia in neurological disorders. The potential roles of neuroendocrine and molecular mechanisms in dysthymia were identified through specific problems related to dysthymia occurring in disorders such as Parkinson's disease, Alzheimer's disease, stroke, multiple sclerosis and epilepsy. This meeting provided direction and opportunity for future studies in the under-recognized and under-investigated relationship between dysthymia and neurological disorders.
format JOUR
author Akiskal, H.S.
Bolis, C.L.
Cazzullo, C.
Costa E Silva, J.A.
Gentil, V.
Lecrubier, Y.
Licinio, J.
Linden, M.
Lopez-Ibor, J.J.
Ndiaye, I.P.
Pani, L.
Prilipko, L.
Robertson, M.M.
Robinson, R.G.
Starkstein, S.E.
Thomas, P.
Wang, Y.
Wong, M.-L.
author_facet Akiskal, H.S.
Bolis, C.L.
Cazzullo, C.
Costa E Silva, J.A.
Gentil, V.
Lecrubier, Y.
Licinio, J.
Linden, M.
Lopez-Ibor, J.J.
Ndiaye, I.P.
Pani, L.
Prilipko, L.
Robertson, M.M.
Robinson, R.G.
Starkstein, S.E.
Thomas, P.
Wang, Y.
Wong, M.-L.
author_sort Akiskal, H.S.
title Dysthymia in neurological disorders
title_short Dysthymia in neurological disorders
title_full Dysthymia in neurological disorders
title_fullStr Dysthymia in neurological disorders
title_full_unstemmed Dysthymia in neurological disorders
title_sort dysthymia in neurological disorders
url http://hdl.handle.net/20.500.12110/paper_13594184_v1_n6_p478_Akiskal
work_keys_str_mv AT akiskalhs dysthymiainneurologicaldisorders
AT boliscl dysthymiainneurologicaldisorders
AT cazzulloc dysthymiainneurologicaldisorders
AT costaesilvaja dysthymiainneurologicaldisorders
AT gentilv dysthymiainneurologicaldisorders
AT lecrubiery dysthymiainneurologicaldisorders
AT licinioj dysthymiainneurologicaldisorders
AT lindenm dysthymiainneurologicaldisorders
AT lopeziborjj dysthymiainneurologicaldisorders
AT ndiayeip dysthymiainneurologicaldisorders
AT panil dysthymiainneurologicaldisorders
AT prilipkol dysthymiainneurologicaldisorders
AT robertsonmm dysthymiainneurologicaldisorders
AT robinsonrg dysthymiainneurologicaldisorders
AT starksteinse dysthymiainneurologicaldisorders
AT thomasp dysthymiainneurologicaldisorders
AT wangy dysthymiainneurologicaldisorders
AT wongml dysthymiainneurologicaldisorders
_version_ 1807315350444834816

Ejemplares similares